Medical policy
Clinical trials background
Medicare covers the routine costs of qualifying clinical trials, as such costs are defined in National Coverage Determination (NCD) 310.1, as well as reasonable and necessary items and services used…
Understanding clinical trials and device coverage
Clinical trials background
What regulatory guidance addresses devices and clinical trials in the Medicare program?
Understanding clinical trials and device coverage
Clinical trials background
What regulatory guidance addresses devices and clinical trials in the Medicare program?
View our Journey to LCD coverage page
Visit our Journey to LCD coverage page to find more information related to LCDs, including the LCD development process and how to become involved, as well as how local and national coverage…
View our Journey to LCD coverage page
Visit our Journey to LCD coverage page to find more information related to LCDs, including the LCD development process and how to become involved, as well as how local and national coverage…
Process flowcharts for new LCD and LCD reconsideration requests
Flowcharts for new LCD and LCD reconsideration requests to provide step-by-step instructions of the processes.
Process flowcharts for new LCD and LCD reconsideration requests
Flowcharts for new LCD and LCD reconsideration requests to provide step-by-step instructions of the processes.
Additional frequently asked questions about clinical trials and device coverage
View these additional FAQs about clinical trials and device coverage.
Multi-jurisdictional contractor advisory committee (CAC) meeting
CAC meetings are for the purpose of discussing literature related to proposed LCDs before they are developed. CAC meetings are open for the public to attend as observers. Read more information…
Transcatheter aortic valve replacement (TAVR)
Important information notifying users of the requirements for approval of transcatheter aortic valve replacement (TAVR) studies.